Ironwood Pharmaceuticals, Inc.

IRWD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$4.42+4.49%

2026-08-03

Financials

Valuation Metrics

Ironwood Pharmaceuticals, Inc.'s Market Cap is $728M. At end of 2025 it was $547M. Ranked #2645 of 3,112 in US market (top 85%), #1118 of 1,445 on NASDAQ (top 77%), #207 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 77%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$728M	US#2,645/3,112 Sec#207/269
Revenue	$362M	US#2,474/3,112 Sec#91/269
Net Income	$102M	US#1,600/3,112 Sec#55/269
Total Assets	$435M	US#2,798/3,112 Sec#175/269
Net Assets	$707M	US#2,004/3,112 Sec#77/269
Value
P/E	7.12x	US#108/3,112 Sec#8/269
P/B	1.03x	US#365/3,112 Sec#15/269
PEG	0.00x	US#7/3,112 Sec#1/269
P/S	2.01x	US#1,270/3,112 Sec#31/269
EV/EBITDA	5.33x	US#182/3,112 Sec#12/269
FCF Yield	15.42%	US#217/3,112 Sec#9/269
Profitability
ROE	14.46%	US#914/3,112 Sec#46/269
ROA	23.51%	US#58/3,112 Sec#13/269
Op. Margin	55.83%	US#80/3,112 Sec#4/269
Revenue Growth	158.87%	US#88/3,112 Sec#25/269
Earnings Growth	2629.20%	US#18/3,112 Sec#3/269
Financial Health
Debt Ratio	92.20%	US#1,003/3,112 Sec#164/269
Total Debt	$597M	US#1,722/3,112 Sec#55/269
FCF	$112M	US#1,620/3,112 Sec#58/269
Cash	$220M	US#1,656/3,112 Sec#108/269
Current Ratio	1.41x	US#1,763/3,112 Sec#248/269
Net Debt/EBITDA	1.82x	US#1,318/3,112 Sec#59/269
Performance
1Y Return	472.98%	US#14/3,112 Sec#7/269
1M Return	2.08%	US#1,338/3,112 Sec#56/269
From 52W High	-23.53%	US#1,881/3,112 Sec#129/269
1Y MDD	-43.60%	US#2,136/3,112 Sec#159/269
Trading
Volume	3,770,420 shares	US#493/3,112 Sec#38/269
Trading Value	$17M	US#2,076/3,112 Sec#161/269
Per Share
EPS	$0.15	US#2,003/3,112 Sec#71/269